IRVINE, Calif., Nov. 1 /PRNewswire-FirstCall/ -- CalbaTech, Inc. , an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, announced today that its wholly owned subsidiary, LifeStem, Inc., filed for US Trademark protection for the name of its stem cell collection service, Stem Cell Microbank, and filed a provisional patent application on the process of the Stem Cell Microbank for its process of stem cell banking. LifeStem believes that it will be the first company to focus on the micro-collection and banking of two different types of stem cells from one client.
"LifeStem's approach is based on the model that it may not be necessary to harvest a regenerative therapeutic amount of stem cells at the time of collection," said CalbaTech CEO James DeOlden. "Our collection service is unique in that stem cells will be collected in non-invasive, micro-quantities and cryo-preserved for cellular expansion at the time of use."
LifeStem, in addition to being the first company to focus on the micro-collection of stem cells, will also be the first company to offer a collection service that collects and stores two different types of stem cells for autologous use. "We believe that it is in the client's best interest to store stem cells from two tissue sources," added LifeStem President Dan Fulkerson. "By preserving two different types of stem cells on a pre-disease basis and making the cells available to the client, the client is afforded two distinct and different stem cell lineages to better suit their particular situation. The benefit to the client is that LifeStem's Microbank storage service allows the client to select the best cell source to be expanded based on the future need."
About CalbaTech
CalbaTech, Inc. is an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions.
About LifeStem
LifeStem, a wholly owned subsidiary of CalbaTech, is positioning itself to become a leading supplier of "Cellular Logistics." The Company's focus is to provide services and technologies to facilitate the efficient acquisition and delivery of adult stem cells, development of stem cell delivery devices for clinical applications and clinical applications of specific stem cell based therapies. The Company has filed a patent application for an endoscopic stem cell delivery device and plans to launch its Stem Cell Microbank in the first quarter of 2006.
Contact: Paul Knopick E&E Communications (949) 707-5365 pknopick@eandecommunications.com
Note: Certain statements in this news release may contain "forward looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, may include forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will be accurate and actual results and future events could differ materially from those anticipated in such statements.
CalbaTech, Inc.CONTACT: Paul Knopick of E&E Communications, +1-949-707-5365,pknopick@eandecommunications.com, for CalbaTech, Inc.
Web site: http://www.CalbaTech.com//
